Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Biomarker Technologies Market Size, Trends, Analysis, and Outlook By Product (Instruments, Assay and Reagents, Consumables), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, Others), By Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032
... Disorders, Others), By Application (Drug Discovery, Diagnostics, Personalized Medicine), by Country, Segment, and Companies, 2024-2032 The global Biomarker Technologies market size is poised to register 14.1% growth from 2024 to 2032, presenting significant growth prospects ... Read More
-
Minimal Residual Disease Market Size, Trends, Analysis, and Outlook By Test, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Next Generation Sequencing (NGS)), By Detection Target (Leukemia, Lymphoma, Solid Tumors, Others), By End-User (Hospitals, Laboratory centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Minimal Residual Disease market size is poised to register 12.6% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the ... Read More
-
Viral Vector and Plasmid DNA Manufacturing Market Size, Trends, Analysis, and Outlook By Type (Viral Vectors, Plasmid DNA), By Products and Services (Product, Services), By Workflow (Upstream Manufacturing, Downstream Manufacturing), By Application (Cell and Gene Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Therapy, Vaccine Development, Research), By Disease (Cancer, Generic Disorders, Infectious Diseases, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Academics and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Viral Vector and Plasmid ... Read More
-
Theranostics Market Size, Trends, Analysis, and Outlook By Product (Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software and Services), By Application (Prostate Cancer, Bone Metastasis, Others, Others), By End-User (Hospitals and Cancer Care Centers, Theranostics Centers, Research and Academic Centers), by Country, Segment, and Companies, 2024-2032
... and Academic Centers), by Country, Segment, and Companies, 2024-2032 The global Theranostics market size is poised to register 10.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
... is projected to reach USD 1.9 billion by 2028 from USD 1.1 billion in 2023, growing at a CAGR of 11.9% during the forecast period. The rising prevalence of cancer and the growing use of ... Read More
-
Global Gastrointestinal Stent Market Size Study & Forecast, By Products (Biliary stents, Duodenal stents, Colonic stents, Pancreatic stents, Esophageal stents) By Material (Self-expanding metal stents, Nitinol, Stainless steel, Other metal stents, Plastic stents) By Application (Biliary diseases, Irritable bowel syndrome, Gastrointestinal cancers, Colorectal cancer, Stomach cancer, Esophageal cancer, Pancreatic cancer) By End Users (Hospitals and Clinics, Ambulatory Surgical Centers) and Regional Analysis, 2023-2030
... (Biliary diseases, Irritable bowel syndrome, Gastrointestinal cancers, Colorectal cancer, Stomach cancer, Esophageal cancer, Pancreatic cancer) By End Users (Hospitals and Clinics, Ambulatory Surgical Centers) and Regional Analysis, 2023-2030 Global Gastrointestinal Stent Market is valued at ... Read More
-
Global Clinical Nutrition Market Size Study & Forecast, By Product (Oral Clinical Nutrition, Parenteral Nutrition, Enteral Feeding Formulas) By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others), By Sales (Retail Sales Channels, Online Sales Channels, Institutional Sales Channels) and Regional Analysis, 2023-2030
... Disorder/Diarrhea, Others), By Sales (Retail Sales Channels, Online Sales Channels, Institutional Sales Channels) and Regional Analysis, 2023-2030 Global Clinical Nutrition Market is valued at approximately USD 29.12 billion in 2022 and is anticipated to grow ... Read More
-
Global Prostate Cancer Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Prostate Cancer Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Prostate Cancer Vaccines. The report also introduces players ... Read More
-
Global Soft Tissue Sarcoma Targeted Drugs Market Growth (Status and Outlook) 2024-2030
... it is expected to grow at a CAGR of % from 2024 to 2030. LPI (LP Information)' newest research report, the “Soft Tissue Sarcoma Targeted Drugs Industry Forecast” looks at past sales and reviews total ... Read More
-
Peptide Synthesis: Global Markets
... news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period. The report will enable ... Read More
-
Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
... (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032 The global oncology biosimilars market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.3 Billion ... Read More
-
Companion Diagnostics Market By Product (Assays, Kits, Reagents, System, Software & Services), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious, Neurology), Sample Type (Tissue, Blood) & Region - Global Forecast to 2029
... 2029 The global companion diagnostics market is projected to reach USD 13.6 billion by 2029 from USD 7.5 billion in 2024, at a CAGR of 12.6% during the forecast period. Factors such as the increasing ... Read More
-
Global chemotherapy-induced thrombocytopenia Market - 2023-2030
... forecast period 2023-2030. Chemotherapy-induced thrombocytopenia (CIT) is characterized by a decreased platelet count in the blood as a result of chemotherapy treatment. Because platelets are necessary for blood clotting, a drop in their number can ... Read More
-
Radiopharmaceuticals Market By End User (Hospitals and Clinics, Medical Imaging Centers, Others), By Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lutetium 177, Copper 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033
... 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033 The radiopharmaceuticals market was valued at $7.9 billion in 2023 and is estimated ... Read More
-
Adrenocortical Carcinoma - Market Insight, Epidemiology And Market Forecast - 2034
... USD 12 million in 2023 and is expected to experience consistent growth during the forecast period (2024–2034). Analysts at DelveInsight project that approximately 54% of the Total Diagnosed Prevalent Cases of Molybdenum Cofactor Deficiency Type ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024
... pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive ... Read More
-
2024 Global Cancer Supportive Care Drugs Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024
... Therapy for Multiple Myeloma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Adult T-Cell Leukemia-Lymphoma - Pipeline Insight, 2024
... Leukemia-Lymphoma market. A detailed picture of the Adult T-Cell Leukemia-Lymphoma pipeline landscape is provided, which includes the disease overview and Adult T-Cell Leukemia-Lymphoma treatment guidelines. The assessment part of the report embraces in-depth Adult T-Cell ... Read More
-
Next Generation Sequencing Market By PRODUCT (Consumables, Platforms, Services), By APPLICATION (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized medicine, Agriculture and animal research, Others), By TECHNOLOGY (Sequencing By synthesis (SBS), Ion semiconductor sequencing (IOS), Sequencing By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... By Ligation (SBL), Pyrosequencing, Single-molecule-real-time sequencing (SMRT), Others), By END USER (Academic and clinical research centers, Pharmaceutical and biotechnology companies, Hospitals and clinics, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The next generation sequencing ... Read More
-
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024
... the Acute Lymphoblastic Leukemia (ALL) market. A detailed picture of the Acute Lymphoblastic Leukemia (ALL) pipeline landscape is provided, which includes the disease overview and Acute Lymphoblastic Leukemia (ALL) treatment guidelines. The assessment part of ... Read More
-
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024
... companies and 3+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Advanced Pancreatic Cancer - Pipeline Insight, 2024
... Cancer market. A detailed picture of the Advanced Pancreatic Cancer pipeline landscape is provided, which includes the disease overview and Advanced Pancreatic Cancer treatment guidelines. The assessment part of the report embraces in-depth Advanced Pancreatic ... Read More
-
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024
... development scenario and growth prospects across the Advanced Breast Cancer in Premenopausal Women market. A detailed picture of the Advanced Breast Cancer in Premenopausal Women pipeline landscape is provided, which includes the disease overview and ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
Research Assistance
